logo-loader

Silence Therapeutics - Proactive One2One Investor Forum May 2019

Published: 00:11 25 May 2019 AEST

David Solomon, chief executive of Silence Therapeutics PLC (LON:SLN), presents at the Proactive Investors One2One Investor Forum in London May 2019.

For more information visit www.silence-therapeutics.com

Australian Strategic Materials signs US$600 million LoI

Rowena Smith, CEO and managing director of Australian Strategic Materials Ltd (ASX:ASM, OTC:ASMMF), joins Jonathan Jackson in the Proactive studio to discuss the company’ s Dubbo Project, in Central West New South Wales. This project aims to extract and process critical minerals and rare earth...

7 hours, 17 minutes ago